Is embryo research and preimplantation genetic diagnosis ethical?
The legal position in the UK on embryo research and preimplantation genetic diagnosis (PGD) is outlined and contrasted with the position in other EU countries. The "gradualist" position of the UK on the moral status of the embryo is defended on the basis of an argument that precaution must be applied in proportion to the degree to which the embryo has developed to display components of agency, on the assumption that mortality is categorically binding and requires agents to be granted rights and that it cannot be known with certainty that the embryo is not an agent. The extent to which this argument, when combined with vicarious protections that the embryo should receive in order to protect the rights of other agents, limits embryo research and PGD, is discussed. It is concluded that the complexities that attend deliberation about the moral problems attending embryo research and PGD are such that the proper response to these problems is via the procedures of political democracy to achieve accountable answers rather than "correct" answers. This allows for a variety of judgements.
Beyleveld
D
D
Sheffield Institute of Biotechnological Law and Ethics (SIBLE), University of Sheffield, Conduit Road, S10 FL, Sheffield, UK. d.beyleveld@sheffield.ac.uk
D001294:Attitude to Health; D003709:Democracy; D004622:Embryo, Mammalian; D004992:Ethics, Medical; D005060:Europe; D006801:Humans; D010686:Philosophy, Medical; D011057:Politics; D019836:Preimplantation Diagnosis / Q000009:adverse effects / Q000592:standards; D012106:Research / Q000331:legislation & jurisprudence* / Q000592:standards; D012945:Social Values; D006113:United Kingdom